Equine fFN antibody and antigen (recombinant protein)

Diagnostic anti-Equine fFN antibodies pairs and antigen for animal health (animal Equine/Horse premature delivery) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-fFN-Ag01Equine fFN$3090.00
GMP-EQU-fFN-Ab01Anti-Equine fFN mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-fFN-Ab02Anti-Equine fFN mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-fFN-Ab03Anti-Equine fFN human monoclonal antibody (mAb)$3090.00
GMP-EQU-fFN-Ab04Anti-Equine fFN human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-fFN-Ag01
Product NameEquine fFN
Target/BiomarkerEquine fFN
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine fFN antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in fFN level test of animal Equine/Horse with premature delivery.
TagHis
Reconized/Reactive SpecicsEquine fFN
Product descriptionRecombinant Equine fFN protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-fFN-Ab01,GMP-EQU-fFN-Ab02
Target/BiomarkerEquine fFN
Product NameAnti-Equine fFN mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine fFN antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine fFN antibodies in Equine fFN level test of animal Equine/Horse with premature delivery.
Product descriptionAnti-Equine fFN mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine fFN antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-fFN-Ab03,GMP-EQU-fFN-Ab04
Target/BiomarkerEquine fFN
Product NameAnti-Equine fFN human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine fFN antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine fFN antibodies in Equine fFN level test of animal Equine/Horse with premature delivery.
Product descriptionAnti-Equine fFN mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine Fetal Fibronectin (e-fFN) stands as an indispensable sentinel in the realm of equine reproductive biology. This glycoprotein, uniquely situated within the amniotic fluid and placental tissues of pregnant horses, orchestrates the symphony of equine pregnancy. Structurally, e-fFN is part of the fibronectin family, a group of adhesive proteins renowned for their roles in cell adhesion and tissue organization.

    At its core, e-fFN serves as a molecular adhesive. During pregnancy, it acts as the adhesive that firmly binds developing equine fetuses to the uterine wall. This adhesion is not merely structural; it is the linchpin that ensures the stability of the maternal-fetal connection. Without the steadfast grip provided by e-fFN, developing foals could be at risk of detachment from the uterine lining, potentially leading to a cascade of complications.

    Beyond its adhesive prowess, e-fFN takes on an additional role in immune regulation. Pregnancy in horses presents a unique challenge for the maternal immune system. It must tolerate the presence of semi-allogeneic fetuses—offspring that share some, but not all, genetic material with the mother. e-fFN actively contributes to immune tolerance, ensuring that the mare's immune system does not launch a hostile response against the developing foal. This immunomodulatory function is pivotal for the success of equine pregnancies.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.